Physicochemical Properties
| Molecular Formula | C21H26N4O4S |
| Molecular Weight | 430.52 |
| Exact Mass | 430.167 |
| CAS # | 2204229-64-9 |
| PubChem CID | 131955136 |
| Appearance | Light yellow to yellow solid powder |
| LogP | 3.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 30 |
| Complexity | 604 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C(C1SC=CC=1OCC)(N1CCN(C2=CC=C([N+]([O-])=O)C(N3CCCC3)=C2)CC1)=O |
| InChi Key | LAYJOGOQGVGOCO-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C21H26N4O4S/c1-2-29-19-7-14-30-20(19)21(26)24-12-10-22(11-13-24)16-5-6-17(25(27)28)18(15-16)23-8-3-4-9-23/h5-7,14-15H,2-4,8-13H2,1H3 |
| Chemical Name | (3-ethoxythiophen-2-yl)-[4-(4-nitro-3-pyrrolidin-1-ylphenyl)piperazin-1-yl]methanone |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | IC50: 0.91 μM (ALDH1A2), Kd: 0.26 μM (ALDH1A2)[1] |
| References |
[1]. Structural Basis of ALDH1A2 Inhibition by Irreversible and Reversible Small Molecule Inhibitors. ACS Chem Biol. 2018;13(3):582-590. |
Solubility Data
| Solubility (In Vitro) | DMSO: 25 mg/mL (58.07 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1 mg/mL (2.32 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 + to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3228 mL | 11.6139 mL | 23.2277 mL | |
| 5 mM | 0.4646 mL | 2.3228 mL | 4.6455 mL | |
| 10 mM | 0.2323 mL | 1.1614 mL | 2.3228 mL |